Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Watch Now
Author(s): Carlos Juanatey Added: 2 years ago
Learn from Dr Carlos Juanatey as he reviews the latest data supporting rhythm control strategies. Key Learning Objectives: The role of rate control and rhythm control strategies Comparing safety, efficacy and quality of life datafor different patient populations Halting Atrial Fibrillation progression with AADs vs. ablation You can also view a roundtable discussion moderated by… View more

Heart Failure

Electrophysiology & Arrhythmia
Rhythm Control in Heart Failure Patients with Atrial Fibrillation
Author(s): William Eysenck , Magdi Saba Added: 3 years ago
Sir James Mackenzie, famous for describing the first mechanistic insights into AF in 1902 using his polygraph, also reported that AF was present in 80–90% of patients who had congestive heart failure (HF) in 1920.1 Today, the conditions are the two ‘epidemics’ of cardiovascular disease.2 They are dominating cardiovascular care and, with increasing longevity, they will become more prevalent and… View more

Heart Failure

Electrophysiology & Arrhythmia
Routine Vs. Aggressive Upstream Rhythm Control - Isabelle Van Gelder
Author(s): Isabelle C Van Gelder Added: 6 years ago
This interview with Isabelle Van Gelder from University of Groningen, Groningen, NL discusses Routine Versus Aggressive Upstream Rhythm Control for Prevention of Early Atrial Fibrillation in Heart Failure (RACE-3). Filmed by Radcliffe Cardiology on-site at ESC 2017. View more

Heart Failure

Electrophysiology & Arrhythmia
Part 5: Drug therapy of PoTS: Rhythm control, Circulatory control
Author(s): Andrew SP Sharp , Melvin D Lobo , Lesley Kavi , et al Added: 3 years ago
In this six-part video panel discussion, Prof Andrew Sharp meets with an expert panel to moderate discussion on the issues surrounding Postural Tachycardia Syndrome (PoTS) which is an abnormality of the automatic nervous system (dysautonomia) that results in abnormal heart rate increases upon standing or sitting. Part five sees Prof Melvin Lobo (Bart's BP Centre of Excellence, UK) discuss drug… View more

Electrophysiology & Arrhythmia

Prevention & Chronic Conditions
AHA 22: EAST-AFNET4: Rhythm Control Therapy in Atrial Fibrillation
Author(s): Shino Kany Added: 1 year ago
AHA 22 - Dr Shino Kany (Broad Institute of MIT and Harvard, Cambridge, MA, US) joins us to discuss the association of genetic risk and outcomes in patients receiving early rhythm control therapy for atrial fibrillation in the EAST-AFNET 4 trial. EAST-AFNET 4 aimed to compare early rhythm control to usual care amongst patients with a recent diagnosis of atrial fibrillation, randomised in a 1:1… View more

Electrophysiology & Arrhythmia
EHRA 22: Early Rhythm Control Therapy For AF Patients
Author(s): Jason G Andrade Added: 2 years ago
In this short late-breaking interview, Dr Jason Andrade (Vancouver General / Montreal Heart Institute, Montreal, CA) joins us at EHRA 2022 to outline the findings of a meta-analysis of EAST-AFNET 4. The main outcomes suggest that early rhythm control therapy is beneficial for AF patients, reducing their cardiovascular outcomes. Discussion points: Reasoning behind this meta-analysis Study… View more

Electrophysiology & Arrhythmia
AHA 21: EAST-AFNET 4: Early Rhythm Control was Consistent in AF Patterns
Author(s): Andreas Goette Added: 2 years ago
In this short video interview, Prof Andreas Goette (St Vincenz Hospital Paderborn, Paderborn, DE) discusses the findings from the the EAST-AFNET 4 Trial. The trial investigated whether rhythm control therapy delivered within one year after AF diagnosis improves outcomes. The trial, presented at AHA 21, demonstrated that clinical benefit of early rhythm control was consistent in AF patterns. … View more

Electrophysiology & Arrhythmia
Author(s): Abhishek Maan , Moussa Mansour , Jeremy N Ruskin , et al Added: 3 years ago
Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice.1 It has been estimated that >3million people in the US and >4.5 million in the EU have paroxysmal or persistent AF.2–4 AF is associated with an approximately fivefold increased risk of stroke,5 threefold risk of heart failure,6 diminished quality of life7 and increased healthcare costs.8,9… View more

Electrophysiology & Arrhythmia
EHRA 22: EAST-AFNET 4 in Clinical Practice
Author(s): Paulus Kirchhof Added: 2 years ago
In this video interview from EHRA 2022, Dr Paulus Kirchhof (University Heart Center Hamburg, Hamburg, DE) discusses the outcomes of the EAST-AFNET 4 Study, and the applicability of these findings in clinical practice. Discussion points: An outline of the EAST-AFNET 4 Study Benefits of early AF treatment Observations from clinical practice Take-home messages Further research required … View more

Electrophysiology & Arrhythmia
Author(s): Alex Baher , Nassir F Marrouche Added: 3 years ago
AF is the most common rhythm disorder. It is estimated AF will affect 6–12 million Americans by 2050 and 17.9 million Europeans by 2060.1–4 AF is responsible for significant morbidity, mortality and healthcare costs.5–7 Heart failure with reduced ejection fraction (HFrEF) is also a rising epidemic that will afflict over 8 million Americans by 2030.8 AF is common in patients with HFrEF9,10 and… View more

Heart Failure

Electrophysiology & Arrhythmia